WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future....
LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work...
Medical cannabis company GW Pharmaceuticals has received the most prestigious official award in British business. The UK-based pharmaceutical firm has...
As reported by Cannabis Health Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with...
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark...
Northern Leaf Jersey-based medical cannabis cultivator Northern Leaf is reportedly aiming to raise a further £3m in pre-IPO funding with...
PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals...
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals...
JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) and its subsidiary, GW Pharmaceuticals (“GW”) – a world leader in discovering, developing and delivering...
GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it...
A new industry report has highlighted the huge “untapped” potential of cannabis-based pharmaceuticals. The report, released on Thursday 2 September...
THE last few weeks have witnessed a wild ride for global cannabis stocks reminiscent of some of the earlier bubbles...
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn. The deal will be...
The cannabis sector is entering Wednesday’s pre-market session in broadly negative territory, with the US benchmark fund MSOS now sitting...
